We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · November 16, 2022

Impact of Vitamin D3 Supplementation as an Adjuvant Therapy to Topiramate Therapy on Pediatric Migraine Prophylaxis

Journal of Child Neurology

 

Additional Info

Journal of Child Neurology
The Impact of Vitamin D3 Supplementation to Topiramate Therapy on Pediatric Migraine Prophylaxis
J. Child Neurol. 2022 Oct 01;37(10-11)833-839, M Kotb Elmala, HA Suliman, AH Al-Shokary, AO Ibrahim, NM Kamal, HH Elshorbagy, KA Nasef, MG El Din Fathallah

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading